Dorsey & Whitney Trust CO LLC acquired a new stake in shares of Coherus BioSciences, Inc. (NASDAQ:CHRS – Free Report) in the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund acquired 10,410 shares of the biotechnology company’s stock, valued at approximately $39,000. Several […]
Memorial Hermann inches closer to Epic install beckershospitalreview.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from beckershospitalreview.com Daily Mail and Mail on Sunday newspapers.
Discover the top priorities of hospital and health system C-suite leaders as they focus on EHRs and workforce management over digital tools to improve patient experience.
Coherus BioSciences (NASDAQ:CHRS – Free Report) had its target price reduced by Robert W. Baird from $11.00 to $9.00 in a report published on Tuesday, Benzinga reports. Robert W. Baird currently has an outperform rating on the biotechnology company’s stock. Other equities analysts have also issued research reports about the company. Truist Financial cut their […]
Coherus BioSciences (NASDAQ:CHRS – Free Report) had its price target lowered by Robert W. Baird from $11.00 to $9.00 in a research note released on Tuesday, Benzinga reports. The brokerage currently has an outperform rating on the biotechnology company’s stock. Other equities research analysts have also recently issued research reports about the stock. StockNews.com assumed […]